PADI2 and COVID-19: Our results also suggest that SNPs in PADI2 and PADI4 play a synergistic role as modifiers of enzymes expression or activity, contributing to the clinical manifestation and outcomes of COVID-19 due to its role in NETosis, cytokine citrullination, platelet activation, and thrombosis (Fig. 3).